About Zeta Corporation
Zeta Corporation provides the highest quality IVD antibodies for Pathology/IHC. Zeta antibodies are carefully curated to produce reproducible results on formalin-fixed, paraffin-embedded (FFPE) sections manually or using commercially available automated equipment.
Zeta designs and develops tumour-specific biomarkers using cutting-edge technology to uniquely select the immunogens for the RAbMono™ (Rabbit Monoclonal) and MonoMAb™ (Monospecific monoclonal) antibodies. Zeta’s MonoMAb™ and RAbMono™ Antibodies are produced through hybridoma and recombinant technologies.
